Workstation developer Silicon Graphics hit the financial marketswith a one-two punch of bad news late last month. The MountainView, CA, company initiated a replacement program to correct problemsin a high-end computer chip and warned that it expects
Workstation developer Silicon Graphics hit the financial marketswith a one-two punch of bad news late last month. The MountainView, CA, company initiated a replacement program to correct problemsin a high-end computer chip and warned that it expects revenuesto be only slightly higher for its first quarter (end-September).
Silicon Graphics chairman and CEO Edward McCracken said thecompany's sluggish sales were due in part to market anticipationof its new O2 workstation, which was introduced on Monday. McCrackensaid the O2 debut was one of SGI's most important new introductionsin several years.
In addition, SGI last month began a replacement program forcustomers who bought workstations shipped between March and Julywith the MIPS R10000 microprocessor. Systems with the affectedmicroprocessors may shut down, the company said. The R10000 chipis a 64-bit microprocessor that was debuted earlier this year(SCAN 1/31/96). Shipments since Aug. 1 are free of the defect.
SGI expected to post revenues only slightly higher than the$758 million recorded last year (including sales of Cray Research,which has SGI acquired), McCracken said. The company said itsnet income will be below market expectations.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.